Oryzon Genomics SA (ORY) — Capital Reinvestment Ratio
Latest as of December 2015:
0.17x
Oryzon Genomics SA (ORY) has a Capital Reinvestment Ratio of 0.17x as of December 2015, meaning it reinvests 0% of its operating cash flow (€523.10K) in capital expenditures (€87.70K). See cash generation quality of Oryzon Genomics SA to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.17x
Capex / Operating Cash Flow
Operating Cash Flow
€523.10K
EUR
Capital Expenditures
€87.70K
EUR
Data as of
Dec 2015
Most recent filing
Oryzon Genomics SA Capital Reinvestment Ratio (2013–2015)
This chart tracks Oryzon Genomics SA's Capital Reinvestment Ratio across 3 annual periods.
Annual Capital Reinvestment Ratio for Oryzon Genomics SA (2013–2015)
Year-by-year Capital Reinvestment Ratio for Oryzon Genomics SA from 2013 to 2015. For live market cap and broader valuation context, see ORY market cap overview.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2015 | 0.17x | €523.14K | €87.65K | ▲ +4222.7% |
| 2014 | 0.00x | €12.13 Million | €47.00K | ▼ -0.6% |
| 2013 | 0.00x | €12.13 Million | €47.30K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow